The Impact of Thrombolytic Therapy on Anxiety, Depression and Quality of Life of Patients with Acute Ischemic Stroke
- PMID: 36752247
The Impact of Thrombolytic Therapy on Anxiety, Depression and Quality of Life of Patients with Acute Ischemic Stroke
Abstract
Background: It is well established that thrombolytic therapy improves the functional recovery by reducing disability measured as National Institutes of Health Stroke Scale (NIHSS) and Rankin score in patients with ischemic stroke. However, the role of alteplase treatment on anxiety and depression in those patients is less clear. Therefore, the aim of this study was to determine whether patients treated with thrombolytic therapy had a better quality of life, less anxiety and depression compared to patients who were not treated with thrombolysis.
Subjects and methods: In this "single canter study" 60 patients with acute ischemic stroke were divided into two groups: alteplase treated (AT) group, and not treated (NT) group. The sociodemographic data including gender, age, marital status, education, employment, financial status, place of residence, refugee status were collected at the beginning of study. The NIHSS score and modified Rankin score (mRS) were performed on admission and at discharge from hospital. Six months following discard from hospital the Beck's Anxiety Inventory (BAI), Beck's Depression Inventory (BDI) and the Short Form 36 quality of life (SF-36 QoL) were performed.
Results: There were no differences in mean NIHSS and mRS at admission to hospital between the groups. At discharge from hospital patients in AT group had significantly lower NIHSS and mRS than patients in NT group. In post-stroke period the patients from AT group had significantly less anxiety and depression than patients from NT group (BAI in AT 6.4+4.17 vs BAI in NT 14.27+7.01 and BDI in AT 9.20+6.61 vs BDI in NT 18.0+7.49). Patients in AT group had significantly better SF-36 QoL score in all components than NT group.
Conclusion: The results of this study showed that thrombolytic therapy reduced the intensity of anxiety and depression and improves the quality of life of patients six months after ischemic stroke.
Similar articles
-
Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.Cerebrovasc Dis. 2016;42(5-6):404-414. doi: 10.1159/000447722. Epub 2016 Jul 8. Cerebrovasc Dis. 2016. PMID: 27387478
-
Transcranial Pulsed Ultrasound with Alteplase Intravenous Thrombolysis for Vascular Recanalisation in Acute Ischemic Stroke.J Coll Physicians Surg Pak. 2020 Jul;30(7):765-767. doi: 10.29271/jcpsp.2020.07.765. J Coll Physicians Surg Pak. 2020. PMID: 32811613 Clinical Trial.
-
Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):779-786. doi: 10.26355/eurrev_202202_27986. Eur Rev Med Pharmacol Sci. 2022. PMID: 35179744
-
Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1046-50. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.023. Epub 2013 Oct 6. J Stroke Cerebrovasc Dis. 2014. PMID: 24103663 Free PMC article.
-
Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.J Stroke Cerebrovasc Dis. 2014 Feb;23(2):204-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.018. Epub 2013 Jan 24. J Stroke Cerebrovasc Dis. 2014. PMID: 23352114
Cited by
-
Behavioral assessment of neuropsychiatric outcomes in rodent stroke models.J Cereb Blood Flow Metab. 2025 Jul;45(7):1232-1248. doi: 10.1177/0271678X251317369. Epub 2025 Mar 20. J Cereb Blood Flow Metab. 2025. PMID: 40110694 Free PMC article. Review.
-
Trajectories and Interactions of Dyadic Coping and Depression in Patients After Thrombolysis for Acute Ischemic stroke: A Longitudinal Study in China.Psychol Res Behav Manag. 2025 May 30;18:1269-1277. doi: 10.2147/PRBM.S525398. eCollection 2025. Psychol Res Behav Manag. 2025. PMID: 40464019 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials